2 results match your criteria: "Hospital of the University of Pennsylvania and Philadelphia VA Medical Center[Affiliation]"
Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy.
ACR Open Rheumatol
September 2023
VA Salt Lake City Healthcare System, Salt Lake City, Utah, and VA Puget Sound Healthcare System, Seattle, Washington.
Objective: In the Steroid EliMination In Rheumatoid Arthritis (SEMIRA) trial, 65% of patients with rheumatoid arthritis (RA) in low disease activity (LDA) on stable biologic therapy successfully tapered glucocorticoids. We aimed to evaluate real-world rates of glucocorticoid tapering among similar patients in the Veterans Affairs Rheumatoid Arthritis registry.
Methods: Within a multicenter, prospective RA cohort, we used registry data and linked pharmacy claims from 2003 to 2021 to identify chronic prednisone users achieving LDA after initiating a new biologic or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD).
Acute hepatitis C: to treat or not to treat?
Hepatology
June 2002
Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, PA, USA.